Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Toxicity to reproduction

Currently viewing:

Administrative data

Endpoint:
toxicity to reproduction
Remarks:
other: Chronic repeated dose toxicity test
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: This is only a short summary of the repeated dose toxicity study related to the reproductive organs, the full study can be found in section 7.5.2
Cross-reference
Reason / purpose for cross-reference:
reference to same study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1995
Report date:
1995

Materials and methods

Principles of method if other than guideline:
Chronic repeated dose toxicity test including macroscopically and gross pathologically assessment of the reproductive organs and tissues.
GLP compliance:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
4,4'-methylenediphenyl diisocyanate
EC Number:
202-966-0
EC Name:
4,4'-methylenediphenyl diisocyanate
Cas Number:
101-68-8
Molecular formula:
C15H10N2O2
IUPAC Name:
1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene
Details on test material:
Monomeric 4,4'-methylenediphenyl diisocyanate (Desmodur 44 M Schuppen from Bayer AG, Leverkusen); 13 batches were tested (purity: >99.5 %)

Test animals

Species:
rat
Strain:
Wistar
Sex:
female
Details on test animals or test system and environmental conditions:
See section 7.5.2a Hoymann et al 1995 (rat, 2y)

Administration / exposure

Route of administration:
inhalation: aerosol
Type of inhalation exposure (if applicable):
whole body
Vehicle:
unchanged (no vehicle)
Details on exposure:
See section 7.5.2a Hoymann et al 1995 (rat, 2y)
Details on mating procedure:
Not included in the test as this is a repeated dose test.
Analytical verification of doses or concentrations:
yes
Details on analytical verification of doses or concentrations:
See section 7.5.2a Hoymann et al 1995 (rat, 2y)
Duration of treatment / exposure:
up to 2 years
Frequency of treatment:
17 hours per day; 5 days per week
Doses / concentrations
Remarks:
Doses / Concentrations:
0, 0.2, 0.7, 2.1 mg/m3
Basis:
nominal conc.
No. of animals per sex per dose:
80 females per dose; at each dose level there were additional 80 rats per group in satellite groups for : chronic toxicity over 12 months (20 animals); lung function over 20 months (12 animals); lung clearance over 20 months (8 animals); bronchoalveolar lavage, biochemistry over 3 months +1 week recovery (20 animals); bronchoalveolar lavage, biochemistry over 12 months + 1 week recovery (20 animals).
Control animals:
yes, sham-exposed
Details on study design:
See section 7.5.2a Hoymann et al 1995 (rat, 2y)

Results and discussion

Overall reproductive toxicity

Reproductive effects observed:
not specified

Any other information on results incl. tables

Full pathological examination was done on 20 rats/dose of a 12 months exposure group and 20 rats/dose of a 24 months exposure group. Reproductive organs assessed included e.g. adrenals, ovaries, uterus, vagina and mammary gland. Compound-related changes were found in the respiratory tract(LOAEC 0.23 mg/m³), but no treatment related findings on reproductive or any other systemic organ effects were reported.

Applicant's summary and conclusion

Executive summary:

In a further chronic inhalation study with respirable aerosols of 4,4’-MDI, 80 female rats per dose group were whole-body exposed to atmospheres of 0.23, 0.70 or 2.05 mg/m³ for 17 hours/day, 5 days /week for up to 24 months. Full pathological examination was done on 20 rats/dose of a 12 months exposure group and 20 rats/dose of a 24 months exposure group. Reproductive organs assessed included e.g. adrenals, ovaries, uterus, vagina and mammary gland. Again compound-related changes were found in the respiratory tract(LOAEC 0.23 mg/m³), but no treatment related findings on reproductive or any other systemic organ effects were reported (Hoymann et al. 1995; see repeated dose toxicity).